(NEO) stock saw a modest uptick, ending the day at $14.71 which represents a slight increase of $0.93 or 6.75% from the prior close of $13.78. The stock opened at $14.95 and touched a low of $14.48 ...

Benchmark analyst maintained a Hold rating on shares of Neogenomics (NASDAQ: NEO). The analysis comes ahead of the company's investor conference presentation scheduled for the same day. The company, ...

On Monday, NeoGenomics, Inc. (NEO) stock saw a decline, ending the day at $12.63 which represents a decrease of $-2.14 or -14.49% from the prior close of $14.77. The stock opened at $14.11 and touched ...

Benchmark Co. analyst Bruce Jackson maintained a Hold rating on NeoGenomics (NEO – Research Report) today. The company’s shares closed ...

NeoGenomics (NEO) shares ended the last trading session 9.1% higher at $13.78. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

NeoGenomics (NASDAQ:NEO – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a note issued to investors on Friday,Benzinga reports. They ...

For further insights into TSE:NEO stock, check out TipRanks’ Stock Analysis page. TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award ...

In the last twelve months Neo Performance Materials insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the ...

NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. FT.

NeoGenomics (NEO – Research Report) received a Hold rating and price target from Benchmark Co. analyst Bruce Jackson today. The company’s ...